Haemophilia
📧 Sign up to get email alerts when something new happens for Haemophilia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2021-07-22Clinical Trial Update: Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A [Phase 4]
Post-marketing safety study update for long-term prophylaxis with Optivate in severe Haemophilia A was terminated; results posted.
-
CLINICAL_TRIALS safety_alert · 2016-11-16Clinical Trial Update: Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database
This document reports post-marketing safety surveillance of NovoSeven in patients with haemophilia using data from the UK Haemophilia Databa…